Discover 2,380 paid clinical trials in Plainfield, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Plainfield offers many clinical trial opportunities with focuses on various conditions, including ADHD, prurigo nodularis, autoimmune diseases like lupus, and cardiovascular conditions. The city's leading institutions are actively recruiting both healthy volunteers interested in paid research options, as well as those with specific health conditions for studies that could lead to groundbreaking discoveries and improved treatments.
Filter
2
Filter results
Results: 2,380
Improving Blood Pressure and Cardiovascular Risk With Resistance Exercise in African Americans
Proton-Spatially Fractionated Radiotherapy and Standard Radiation Therapy for the Treatment of Newly Diagnosed Retroperitoneal Soft Tissue Sarcoma
for
Retroperitoneal Sarcoma
Location: Chicago IL
Sponsor: Northwestern University
Sex: All
Age: 18+
Code: NCT06327477
Phase 1, Phase 2, Recruiting
An Investigational Scan (rhPSMA-7.3 PET/CT) for Detecting Biochemically Recurrent Prostate Cancer, ENLIGHTEN Trial
for
Biochemically Recurrent Prostate Carcinoma,
Location: Chicago IL
Sponsor: Northwestern University
Sex: Male
Age: 0+
Code: NCT06813898
Early Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Chicago IL, La Crosse WI, St Louis MO, Dayton OH,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06973187
Phase 3, Recruiting
Study of Biomarker-Based Treatment of Acute Myeloid Leukemia
A Trial to Assess the Efficacy and Safety of Engasertib in Participants With Moderate to Severe Hereditary Hemorrhagic Telangiectasia (HHT)
for
Hereditary Hemorrhagic Telangiectasia
Location: Chicago IL, Indianapolis IN, St Louis MO, Rochester MN
Sponsor: Vaderis Therapeutics AG
Sex: All
Age: 18+
Code: NCT07743671
Phase 3, Recruiting
Oxalate and Citrate in Humans - Response to Citrate
for
Kidney Stone, Healthy
Location: Chicago IL
Sponsor: University of Chicago
Sex: All
Age: 18 - 70
Code: NCT06944223
Recruiting
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
for
Untreated, Unresectable, or Metastatic Colorectal Cancer
Location: Chicago IL, Iowa City IA, St Louis MO, Columbus OH,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07221357
Phase 2, Phase 3, Recruiting
A Study to Learn About the Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Late Isolated Microvascular Inflammation
for
Microvascular Inflammation
Location: Chicago IL, Milwaukee WI, St Louis MO, Ann Arbor MI,
Sponsor: Biogen
Sex: All
Age: 18 - 70+
Code: NCT07219043
Phase 2, Recruiting
Efficacy and Safety of 4F-PCC (4-Factor Prothrombin Complex Concentrate) in Adult Patients Undergoing Complex Cardiovascular Surgery With Cardiopulmonary Bypass (CPB)
for
Complex Cardiovascular Surgery With Cardiopulmonary Bypass
Location: Chicago IL, Cincinnati OH, London, Toronto,
Sponsor: CSL Behring
Sex: All
Age: 18+
Code: NCT07094087
Phase 3, Recruiting
To Evaluate the Safety and Efficacy of MANP in Subjects With Difficult to Control/ Resistant Hypertension
for
Difficult to Control Hypertension
Location: Chicago IL, Flint MI, Dearborn MI, Little Rock AR,
Sponsor: E-Star BioTech, LLC
Sex: All
Age: 18 - 70+
Code: NCT06343298
Phase 2, Recruiting
Prospective Randomized Trial Comparing Longitudinal vs. Transverse A1 Pulley Release
for
Trigger Finger, Stenosing Tenosynovitis
Location: Chicago IL, St Louis MO
Sponsor: Washington University School of Medicine
Sex: All
Age: 18+
Code: NCT07516652
Recruiting
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
for
Non-small Cell Lung Cancer (NSCLC)
Location: Chicago IL, Evanston IL, Peoria IL, Fort Wayne IN,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07361497
Phase 3, Recruiting
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
for
Myelofibrosis
Location: Chicago IL, St Louis MO, Ann Arbor MI, Columbus OH,
Sponsor: Sumitomo Pharma America, Inc.
Sex: All
Age: 18+
Code: NCT04176198
Phase 1, Phase 2, Recruiting
VIVID - Valvular and Ventricular Improvement Via iCoapsys Delivery - Feasibility Study
for
Mitral Valve Regurgitation, Left Ventricular Dysfunction,
Location: Evanston IL, Minneapolis MN, Shawnee Mission KS,